107 related articles for article (PubMed ID: 23118038)
1. Aliskiren, at low doses, reduces the electrical remodeling in the heart of the TGR(mRen2)27 rat independently of blood pressure.
De Mello W; Rivera M; Rabell A; Gerena Y
J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):23-33. PubMed ID: 23118038
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone enhances the beneficial effect of aliskiren on cardiac structural and electrical remodeling in TGR(mRen2)27 rats.
De Mello WC
J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):488-94. PubMed ID: 24036520
[TBL] [Abstract][Full Text] [Related]
3. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
[TBL] [Abstract][Full Text] [Related]
5. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
Crespo MJ; Cangiano JL; Altieri PI; Escobales N
J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
[TBL] [Abstract][Full Text] [Related]
8. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
[TBL] [Abstract][Full Text] [Related]
9. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
[TBL] [Abstract][Full Text] [Related]
10. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
11. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
12. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
13. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure.
Westermann D; Riad A; Lettau O; Roks A; Savvatis K; Becher PM; Escher F; Jan Danser AH; Schultheiss HP; Tschöpe C
Hypertension; 2008 Dec; 52(6):1068-75. PubMed ID: 18955663
[TBL] [Abstract][Full Text] [Related]
15. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I
Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571
[TBL] [Abstract][Full Text] [Related]
16. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
Fischer R; Dechend R; Qadri F; Markovic M; Feldt S; Herse F; Park JK; Gapelyuk A; Schwarz I; Zacharzowsky UB; Plehm R; Safak E; Heuser A; Schirdewan A; Luft FC; Schunck WH; Muller DN
Hypertension; 2008 Feb; 51(2):540-6. PubMed ID: 18158339
[TBL] [Abstract][Full Text] [Related]
17. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction.
Solomon SD; Shin SH; Shah A; Skali H; Desai A; Kober L; Maggioni AP; Rouleau JL; Kelly RY; Hester A; McMurray JJ; Pfeffer MA;
Eur Heart J; 2011 May; 32(10):1227-34. PubMed ID: 21317148
[TBL] [Abstract][Full Text] [Related]
18. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Cooper SA; Demarco VG; Hayden MR; Stump CS; Link D; Ferrario CM; Sowers JR
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E103-9. PubMed ID: 18460596
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.
Shah AM; Shin SH; Takeuchi M; Skali H; Desai AS; Køber L; Maggioni AP; Rouleau JL; Kelly RY; Hester A; Keefe D; McMurray JJ; Pfeffer MA; Solomon SD
Eur J Heart Fail; 2012 Feb; 14(2):185-92. PubMed ID: 21965526
[TBL] [Abstract][Full Text] [Related]
20. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.
Fogari R; Zoppi A; Maffioli P; Monti C; Lazzari P; Mugellini A; Derosa G
Diabetes Obes Metab; 2012 Apr; 14(4):341-7. PubMed ID: 22074122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
